«We have created a year's stock of medicines and substances,» Petr Bely at the meeting of the Council on Intellectual Property of the Federation Council

Promomed 18 April 2022

On Friday, speaking at a meeting of the Council on Intellectual Property of the Federation Council of the Russian Federation, the Chairman of the Board of Directors of Promomed Group Petr Bely assured Valentina Matvienko, Chairman of the Federation Council of the Federal Assembly of the Russian Federation and all participants of the event held on April 15 in Saransk that there will be no shortage of medicines in Russia.


«As a representative of a large Russian pharmaceutical company, I want to assure you that there will be no shortage of medicines in the country. We have created a stock of drug products and substances in the anti-COVID portfolio and main antibiotics for a year ahead. We will provide our country with medicines,» Petr Bely stressed.

Promomed Group is one of the leaders in Russia in terms of the number of clinical trials. The company is actively increasing its portfolio of original innovative drugs of own development. About ten new medicines are at research and approval stages. The company specializes in vital nosologies – endocrinology, neurology, oncology, infection control and a number of others. Promomed Group has one of the widest portfolios of anti-COVID drugs, including original direct-acting antivirals, anticoagulants, antibiotics, drugs for the treatment of complications and long COVID.

«Our goal is to provide medicines, advanced innovative drugs to population,» Petr Bely said in his speech.